Provided by Tiger Trade Technology Pte. Ltd.

Tscan Therapeutics, Inc.

1.03
+0.119613.14%
Volume:1.08M
Turnover:1.05M
Market Cap:58.45M
PE:-0.92
High:1.04
Open:0.9382
Low:0.8950
Close:0.9104
52wk High:2.57
52wk Low:0.8824
Shares:56.75M
Float Shares:44.03M
Volume Ratio:2.36
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1200
EPS(LYR):-2.2530
ROE:-76.44%
ROA:-30.45%
PB:0.41
PE(LYR):-0.46

Loading ...

Lynx1 Capital Management Reports Acquisition of TScan Therapeutics Common Shares

Reuters
·
Dec 24, 2025

TScan Therapeutics Reports Positive Phase 1 Results for TSC-101 in Heme Malignancies

Reuters
·
Dec 07, 2025

TScan Therapeutics Announces Updated ALLOHA Phase 1 Trial Data and Plans for Pivotal Study in 2026

Reuters
·
Dec 04, 2025

TScan Therapeutics Approves Key Employee Retention Program

TIPRANKS
·
Nov 27, 2025

TScan Therapeutics Expects $2.3 Million One-Time Charge For Severance During 3 Months Ended Dec 31

Reuters
·
Nov 20, 2025

TScan Therapeutics (TCRX) was downgraded to a Hold Rating at Morgan Stanley

TIPRANKS
·
Nov 14, 2025

H.C. Wainwright Keeps Their Buy Rating on TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 13, 2025

LifeSci Capital Reaffirms Their Buy Rating on TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 13, 2025

TScan Therapeutics Q3 revenue jumps

Reuters
·
Nov 12, 2025

BRIEF-TScan Therapeutics Q3 Net Income USD -35.71 Million

Reuters
·
Nov 12, 2025

TScan Therapeutics Q3 Income From Operations USD -37.052 Million

THOMSON REUTERS
·
Nov 12, 2025

LifeSci Capital Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 12, 2025

TScan Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

LifeSci Capital Sticks to Its Buy Rating for TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 05, 2025

TScan Therapeutics Inc : Btig Cuts to Neutral From Buy

THOMSON REUTERS
·
Nov 04, 2025

Barclays Reaffirms Their Buy Rating on TScan Therapeutics (TCRX)

TIPRANKS
·
Nov 04, 2025

TScan Therapeutics to reduce workforce by 30%

TIPRANKS
·
Nov 03, 2025

BRIEF-TScan Therapeutics Announces 30% Workforce Reduction, Cash Runway Extension

Reuters
·
Nov 03, 2025

BRIEF-TScan Therapeutics Expects $2.3 Million One-Time Charge For Severance During 3 Months Ended Dec 31

Reuters
·
Nov 03, 2025

TScan Therapeutics Inc - Expects $2.3 Mln One-Time Charge for Severance During 3 Months Ended Dec 31 - SEC Filing

THOMSON REUTERS
·
Nov 03, 2025